REGENERON PHARMACEUTICALS, INC.

FundStock

CIK 0000872589 · Q2 2026

13F Equity AUM

$177.2M

+270.1% QoQ

Positions

+1 QoQ

AUM Rank

#6,633

Top 76%

Skill Alpha (FF)

—

Building track record (6q)

Quarters Tracked

~1 years

Portfolio Concentration

Top 5: 100.0%Top 10: 100.0%Top 20: 100.0%

Parabilis Medicines, Inc.64.3%

NTLA35.4%

ACET0.3%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Unclassified64.3%

Healthcare35.6%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 3Median: 35.35%Avg: 33.33%

0–0.5%

1(0.3%)

0.5–1%

0(0.0%)

1–3%

0(0.0%)

3–5%

0(0.0%)

5%+

2(99.7%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 3vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New2Increased0Decreased0Exited1

New Positions

Parabilis Medicines,…64.3%

+4.2M

ACET0.3%

+61K

Exited

TORCEUR

-60,511

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...